Release Date: 08/03/16 09:15 Summary: Broadspectrum Expands Social Portfolio Price Sensitive: Yes Download Document 69.88KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%